Dr Reddy's divests two antibiotic brands Ciprolet and Levolet in Russia & CIS countries https://ift.tt/CuxWqsp

Dr Reddy's said the divestment of brands from its non-core areas will allow the company to focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/me07hKI